• AI-powered Digital Pathology Workflows Support Confident Cancer Diagnosis

    Oct 10 | Diagnostics World | There are more cases of cancer in the U.S. than ever before. Over 2 million new cases are expected to be diagnosed in 2025 alone, and cancer incidence is on the rise in 6 of the 10 most common cancers. Delivering speedy, accurate diagnoses and treatment for a growing pool of cancer patients is a daunting challenge for today’s clinicians. More

  • Beyond the Brain Scan: How Emerging Blood Tests Could Change the Way Neurodegenerative Diseases are Detected and Diagnosed Down the Road

    Oct 01 | Diagnostics World | We have entered a new era of science focused on developing tools and technologies to support early detection and diagnosis. The rapid evolution of research has led to the need to systematically collect, review, and distill findings into clear and actionable recommendations for how to use these tools in clinical practice More

  • ‘Super-Simple’ NLP Model Labels Origin of Metastatic Cancer

    Sep 30 | Diagnostics World | For patients with metastatic brain cancer, stereotactic radiosurgery has become an increasingly common treatment over the past decade based on the recommendations of medical physicists, guidelines of professional societies, and coverage guidelines of federal agencies. There has also been a change in the drugs used to treat the underlying cancer in conjunction with the procedure, especially in cases of metastatic cancer. More

  • GE Healthcare Acquires icometrix, Beckman Coulter Launches First Fully Automated BD-Tau Immunoassay Test, More

    Sep 25 | Diagnostics World | GE HealthCare enters an agreement to acquire icometrix; Beckman Coulter Diagnostics launches the industry's first fully automated brain-derived Tau (BD-Tau) research use only (RUO) immunoassay test; and more. More

  • Follow the Money: Blood-Based Ovarian Cancer Test, Esophageal Diagnostic Platform, More

    Sep 24 | Diagnostics World | Mercy BioAnalytics will commercialize their blood-based ovarian cancer test portfolio; Cyted Health will accelerate the commercial expansion of their diagnostics platform in the U.S.; and more. More

  • Apple Watch Receives FDA Clearance for Hypertension Notifications

    Sep 18 | Diagnostics World | Last week Apple introduced Apple Watch Series 11, offering the most comprehensive set of health features yet, longer battery life, an even more durable cover glass, and 5G cellular capabilities, all in its thinnest and most comfortable design. Among the new features, Apple Watch Series 11 introduced FDA-cleared hypertension notifications, which can alert users if signs of chronic high blood pressure — or hypertension — are detected. More

  • Biomarker Combo Could Guide Treatment of Recurring Ovarian Cancer

    Sep 17 | Diagnostics World | Ovarian cancer relapse is a remarkably diverse and dynamic immunological event that when mapped in conjunction with the genomic characteristic of tumors can provide actionable insights about how to enhance the effectiveness of chemotherapy in extending remission and prolonging survival. That’s the promising possibility suggested by researchers in the field who have newly defined four immunologic subtypes of recurrent ovarian cancers. More

  • AI-Stethoscope Increases Cardiac Condition Diagnoses in Routine Care

    Sep 16 | Diagnostics World | Results from one of the largest randomized evaluations of AI in routine care showed that an AI-enabled digital stethoscope significantly increased the number of major cardiac conditions detected compared to the standard of care. The study was led by Imperial College London and Imperial College Healthcare NHS Trust and the results were presented last week at the European Society of Cardiology Congress in Madrid. More

  • Qure.ai Scans Routine Chest X-Rays for Early Cancer Diagnoses

    Sep 11 | Diagnostics World | A clinical case study from Qure.ai and Hacettepe University, Turkey, delivered at the IASLC World Conference on Lung Cancer 2025 in Barcelona, shows that Artificial Intelligence (AI) can detect potentially malignant pulmonary nodules on routine chest X-rays, even when the imaging was ordered for unrelated, non-respiratory conditions. More

  • Decoding Immune Cell Dialogue to Predict Immunotherapy Responses

    Sep 09 | Diagnostics World | There is a lack of reliable predictive methods that can determine how a patient will respond to certain immunotherapies and understanding how immune cells communicate with each other may be the key to understanding the differences. A team of researchers have created a new technology called Interact-omics that can “listen in” on this immune cell dialogue. More
View more articles

 
DXX-Industry-spotlight

merck


Custom Diagnostic Antibody Development & Manufacturing Services

Overcome Process Challenges by outsourcing your custom antibody production to us. How partnering with an antibody production expert can improve your assay, accelerate launch, and maintain your manufacturing.

Learn more